Inpatient and Outpatient Orderable

Interleukin-6 Build info

Synonyms

  • INTERLEUKIN-6
  • IL6
  • LAB332

Procedure Name

INTERLEUKIN-6

Procedure Master Number

LAB332

Procedure ID

1774

Clinical Info

Elecsys IL-6 immunoassay is an in-vitro diagnostic test for the quantitative determination of IL-6 (interleukin-6) in human serum and plasma.1,2 This assay is used to assist in identifying severe inflammatory response in patients with confirmed COVID-19 illness to aid in determining the risk of intubation with mechanical ventilation, in conjunction with clinical findings and the results of other laboratory testing.

Specimen Sources

Blood, Arterial Blood, Capillary Blood, Central Line Blood, Venous

Specimen Types

Blood

Container

Red Top Tube

Collection Instructions

Container/Tube: Red top or Gold top tube(s)
Specimen: 1 mL of serum (1 mL min)
Transport Temperature: Frozen
Stability: 1 Day Refregerated 
                14 Days Frozen
 

Specimen Volume

1 mL of serum (1 mL min)

Transport Instructions

Frozen

Specimen Stability

1 Day Refregerated 
                14 Days Frozen
 

Methodology

Electrochemiluminescence Immunoassay (ECLIA)

Days Performed

Results available: 3-5 Days

Performing Laboratory

LabCorp of America

CPT

83520
 
LOINC Code:  26881-3

PDM

5902163

Only Orderable at Locations:

Orderable Everywhere

Results

Component Name Base Name Common Name External Name
INTERLEUKIN 6 INTERLEU6 INTERLEU 6 Interleukin-6

Result Interpretation

0.0-13.0 pg/mL:
Based on the available clinical data, PCR-confirmed COVID-19 patients
with IL-6 concentrations >35.0 pg/mL at presentation are at risk for
mechanical ventilation during their hospitalization. IL-6 values
should be used in conjunction with clinical findings and the results
of other laboratory findings. IL-6 values alone are not indicative of
the need for endotracheal intubation or mechanical ventilation.

Forms

edit